Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Possible Augmentation Of NB-UVB Induced Pigmentation In NSV By Carboxy.
Official title: Evaluation Of Carboxytherapy As An Adjuvant To Narrowband-Ultraviolet B Phototherapy For The Treatment Of Stable Non-Segmental Vitiligo: A Clinical And Biochemical Study .
Status: Closed to new participants
Description:
Patients with stable vitiligo with 2 or more symmetric patches, 2 on acral sites and/or 2 on non acral sites will be recruited and assessed for eligibility for inclusion to receive NB-UVB on the whole body, and carboxytherapy on one randomized side.
Phase: Phase 4.
What is being studied: devices — NB-UVB alone, NB-UVB combined with carboxy.
Who can take part: ages 18 Years, 59 participants planned.
Enrollment status: the registry has not updated this study since its planned completion date, so its current status is unclear. The study started 15 September 2024 and was due to finish 01 June 2026.
Source: ClinicalTrials.gov, NCT07563049 (https://clinicaltrials.gov/study/NCT07563049).
Start date: September 15, 2024
Completion date: June 01, 2026
Organizer: Kasr El Aini Hospital
Link: https://clinicaltrials.gov/study/NCT07563049
The registry does not list a contact for this study. Use the link above to reach the study record on ClinicalTrials.gov.
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- PTSD in Vitiligo?
Living with vitiligo often involves more than managing visible skin changes. Many individuals face discrimination, social stigma, and feelings of isolation, leading to emotional...
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a generally unpredictable skin disease that causes a gradual loss of skin color and overlying hair on different parts of the body. Contr...
- How smoking affects vitiligo?
Smoking is a common habit linked to numerous health risks, affecting multiple body systems and increasing various disease risks, including respiratory and cardiovascular issues....
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.